R3D, I don't buy your story.
I may be in the dark but maybe it is time to shed a little light on you.
If you truly believed ANI was worthless as the markets lead us to believe, why are you here. You would have moved on. The fact you are still hear and continue to declare I am delusional as to where I believe we should be if treated like the other stocks that ANI is admittedly chasing, leads me to believe that you don't want ANI to be treated like other stocks in the same pharmaceutical family.
Which raises two very distinct possibilities:
1) You are accumulating and my info if taken seriously and catches on or pulls people in as you say, could help elevate the share price, or
2) You are shorting the stock, which I doubt you would do without covering the other side of the paint.
The way you talk you are basically saying that ANI will never get any respect. It actually looks like you want to chase away investors.
I truly believe in what I am saying, unfortunately I don't think you can say the same.
I took the time to speak to the CEO and got to see where he was going with the company and he referred me to the S4. He allayed my fears about selling off Libigel at a rock bottom price. Hopefully he will articulate the seeking of a partner for Libiegl in the Q3 filing. The more you look at the S4 and the more you compare ANI to the companies listed in the comparative analysis, the more you understand the value of the company. Which has yet to make it to the street. Don't know about you, but isn't that the best time to buy, before the others catch on.
AI
Market Data 
Markets 
